Delivery Order SPE2DB22D3011-SPE2DB24FP8KE
Award Date 1/3/24
Potential Completion Date 1/4/24
Potential Value $74K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,268.60 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The delivery order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $22,690.64 award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The delivery order has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,437.35 firm-fixed-price contract is for the supply of 4565452753 MENQUADFI VIAL 0.5ML pharmaceutical products. The award has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that supports various government agencies and healthcare programs through multiple indefinite delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The award, valued at $7,024.80, is a firm-fixed price delivery order that has an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no indication of any subcontractors. This delivery order is likely part of a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,756.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is for the supply of 4564736964 ! MENQUADFI VIAL 0.5ML medical products. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $9,039.53, is for MENQUADFI VIAL 0.5ML medical supplies. The contract has a period of performance through January 9, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products and medical supplies. The delivery order, valued at $6,038.37, is for the provision of MENQUADFI VIAL 0.5ML and has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is valued at $166,411.05 and is for the delivery of pharmaceutical products and medical supplies. The order is a firm-fixed-price contract with an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $4,302.40, is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...